Use lay language. The aim of this study is to evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.
Protocol description Visit D0 * patient inclusion after informed signed consent * clinical exam * blood sampling (magnesium dosage) * questionnaires (neuropathic pain and quality of life) * daily self-evaluation on neuropathic pain scale (Week0 to Week5) D8 : first intake of study drug (magnesium or placebo) Visit Week5: * questionnaires (neuropathic pain and quality of life) * blood sampling (magnesium dosage) * clinical exam
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
50
evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.
CHU Clermont-Ferrand
Clermont-Ferrand, France
Pain scores (neuropathic pain evaluation questionnaire)
Time frame: Visit D0
- Numeric scale - quality o f life questionnaires
Time frame: Visit Week 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.